UNSPSC 51293009: Amineptine

This classification denotes an antidepressant agent with the molecular formula C22H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 27T1I13L6G, chemically known as 7-((10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)amino)heptanoic acid but generally known as amineptine, which bears US NIH Compound Identifier 34870. Amineptine most often comes in base and hydrochloride forms. European Medicines Agency schedules Amineptine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05435MIG.

UNSPSC 51293009 Amineptine is a Commodity code for pharmaceutical products, but the recent state and local opportunities associated with it diverge sharply from the code's nominal scope. The three recent solicitations involve naloxone and drug deactivation systems (a harm-reduction product), an exploratory request for information about direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products distributed through established wholesaler networks. None of these procurements concern amineptine specifically. The code shows little relevant recent activity in state and local contracting, and the opportunities posted under it appear to reflect catalog or taxonomy classification mismatches rather than sustained demand for amineptine itself.

Issuing bodies include a Florida county health department (Seminole County), a state health and human services commission (Texas HHS), and a multi-state cooperative purchasing alliance (MMCAP, administered by Minnesota). The Seminole County IFB60459723LAS is a traditional competitive bidding process for naloxone and drug deactivation systems with quarterly deliveries, due July 26, 2023. Texas HHS's RFI HHS0017013, posted April 3, 2026, seeks market intelligence on direct-to-manufacturer pharmacy contracting models before formal procurement. MMCAP's RFP S1070000015802, due March 26, 2026, establishes multi-award contracts for generic pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon through three authorized wholesalers (Cencora, Cardinal Health, and Morris & Dickson), with pricing weighted 75 percent of evaluation. Business development professionals should treat this code as inactive for amineptine procurement and verify correct code assignment before pursuing opportunities posted under it.